Pandurangi, Ananda K 1 CURRICULUM VITAE Name in full: Ananda K. Pandurangi Date of Birth: July 8, 1951 Place of Birth: Dharwar, India Citizenship: U.S.A. Office Address & Phone: Department of Psychiatry Virginia Commonwealth University Box 980710, Richmond, Virginia, 23298 Phone: (804) 828-4570, Fax: (804) 828-4614 [email protected]Current Position: - Professor of Psychiatry - Adjunct Professor of Radiology - Director, Schizophrenia Program, and Brain Stimulation Therapy Program - Medical Director, Adult & Geriatric Inpatient Services & Emergency Psychiatric Services - Chairman, Division of Inpatient Psychiatry - Vice-Chair, Department of Psychiatry Virginia Commonwealth University Health System Licensure: Commonwealth of Virginia #36782 (active) Commonwealth of Massachusetts #46429 (registration inactive) State of New York #150819 (registration inactive) Madras Medical Council, India, #26390 Boards/Certification: M.B.B.S., JIPMER, Pondicherry, India, 1975 University of Madras, Madras (aka Chennai), India Educational Council for Foreign Medical Graduates, USA, 1975 (Certificate # 231-506-7) M.D. (Psychological Medicine), NIMHANS, Bangalore University, Bangalore, India, 1978 Diplomate, American Board of Psychiatry and Neurology, U.S.A., 1985 (Certificate #27120) Certification in Clinical Psychopharmacology, American Society of Clinical Psychopharmacology, 1998-2008
Transcript
Pandurangi, Ananda K
1
CURRICULUM VITAE
Name in full: Ananda K. Pandurangi Date of Birth: July 8, 1951 Place of Birth: Dharwar, India Citizenship: U.S.A. Office Address & Phone: Department of Psychiatry Virginia Commonwealth University
- Adjunct Professor of Radiology - Director, Schizophrenia Program, and Brain
Stimulation Therapy Program - Medical Director, Adult & Geriatric Inpatient
Services & Emergency Psychiatric Services - Chairman, Division of Inpatient Psychiatry - Vice-Chair, Department of Psychiatry Virginia Commonwealth University Health System
Licensure: Commonwealth of Virginia
#36782 (active) Commonwealth of Massachusetts #46429 (registration inactive) State of New York #150819 (registration inactive) Madras Medical Council, India, #26390
Boards/Certification: M.B.B.S., JIPMER, Pondicherry, India, 1975
University of Madras, Madras (aka Chennai), India Educational Council for Foreign Medical Graduates, USA, 1975 (Certificate # 231-506-7) M.D. (Psychological Medicine), NIMHANS, Bangalore University, Bangalore, India, 1978 Diplomate, American Board of Psychiatry and Neurology, U.S.A., 1985 (Certificate #27120) Certification in Clinical Psychopharmacology, American Society of Clinical Psychopharmacology, 1998-2008
Pandurangi, Ananda K
2
Education: Clinical Research Fellow, Department of Psychiatry July 1982 - June 1984 College of Physicians & Surgeons, Columbia
University, New York, New York
July 1982 - June 1983 Resident in Psychiatry New York State Psychiatric Institute New York, New York
July 1980 - June 1982 Resident in Psychiatry Upstate Medical Center, SUNY, Syracuse, NY
July 1979 - June 1980 Intern, Medicine/ Psychiatry Program Upstate Medical Center, SUNY, Syracuse, NY
July 1975 - June 1978 Resident in Psychiatry
National Institute of Mental Health & Neuro-Sciences, Bangalore University, Bangalore, India
Jan 1974 - March 1975 Intern
JIPMER Hospital, Pondicherry, India
April 1975 - July 1975 Senior Houseman (Psychiatry, Chest Diseases) JIPMER Hospital, Pondicherry, India
July 1968 – December 1974 Medical Student, Jawaharlal Institute of Post-
Graduate Medical Education and Research (JIPMER), Pondicherry, Madras University, India
July 1967 - June 1968 Pre-University Course, National College
Bangalore, India
Academic Appointments: July 1995 - Professor of Psychiatry (tenured)
Adjunct Professor of Radiology, MCV/VCU July 1990 - June 1995 Associate Professor of Psychiatry (with tenure)
& Adjunct Associate Professor of Radiology, MCV/VCU
July 1984 - June 1990 Assistant Professor of Psychiatry Adjunct Assistant Professor of Radiology, (1988 - ), MCV/VCU
July 1979 - June 1982 Assistant Instructor, Department of Psychiatry SUNY, Syracuse, NY
July 1978 - June 1979 Research Associate and Lecturer in Psychiatry National Institute of Mental Health & Neuro-
Sciences, Bangalore, India
Pandurangi, Ananda K
3
Membership in Scientific & Professional Organizations: • American Psychiatric Association - Distinguished Fellow (2002-present), Fellow
(1993-2001), Member (1980 –93’) & Psychiatric Society of Virginia (1984-present)
• Indian Psychiatric Society, Member (1976-85’), Fellow (1985-90), Life Fellow (2007 - )
• Society of Biological Psychiatry, Member (1984-present) • Indo-American Psychiatrists Association, U.S.A (1983-present), Virginia Chapter
(1985-present). • Society for Neuroscience, Central Virginia Chapter (1986-1999) • New York Academy of Sciences, Member (1987-2000) • American Society of Clinical Psychopharmacology, Member (1993-present) • International Society for Electroconvulsive Therapy and NeuroStimulation
(previoulsy Society for Convulsive Therapy) (2001-present) • American Association of Physicians from India (2001 – present)
Membership in Community Organizations:
• National Alliance for the Mentally Ill Virginia Chapter (1984-present) • Board of Directors Gateway Homes Foundation (for the chronic mentally ill),
Richmond, Virginia (1985-1991)and Member, Professional and Resident Care Committees (1985-1989).
• Hindu Center of Virginia (1984-present) - Member (84-88), Life Member (89-present), Corporate Member (94'- present)
• Board of Directors Bharat Swamukti Foundation (India Self-Liberation Foundation) Ohio, U.S.A. (1989-present)
• Advisory Council Member Richmond City Street Team (for the Homeless Mentally Ill), 1988-1990
• Richmond Kannadigas - South Indian language-based cultural group (1984-present)
• Board of Directors, Bexley Neighborhood Association, Richmond, VA (2003) • Inter Faith Council of Greater Richmond – Presenter (2002, 2003, 2004)
Special Awards/Honors:
• Second Rank, Bangalore University, India (1967) in Pre-University Course (out of approximately 10,000 students)
• National Merit Scholar, India (1968-1974) • Distinction in Physiology, JIPMER, University of Madras, India (1970) • Nominated for Laughlin Fellowship of American Psychiatric Association, 1979 • Young Investigator in Schizophrenia Research Award, International Congress of
Schizophrenia Research, USA (1987) • Special Award For Expert and Compassionate Care: Virginia Alliance For The
Mentally Ill,(1988) • Excellence in Service Award (1991, 1999) Department of Psychiatry, MCV/VCU • Exemplary Psychiatrist Award: The National Alliance for the Mentally Ill, 1992 • Fellow, American Psychiatric Association (1993) • "Professional of the Year" Award Central Virginia Alliance for the
Pandurangi, Ananda K
4
Mentally Ill (1993) • Marquis Who's Who in Science & Engineering 2nd Edition, 1994-95 • The Best Doctors in America: Woodward/White, Inc 1995, 1998, 2001, 2004,
2006, 2008, 2010, 2012 • Nancy C.A. Roeske Certificate of Excellence in Teaching, American Psychiatric
Association 1996 • Indo-American Psychiatrists Association Science Award, 1999 • Outstanding Teacher Award: Chosen by the Residents of the Department of
Psychiatry, MCV/VCU, 2004 • The Hippocampal Award: Residents of the Department of Psychiatry, Virginia
Commonwealth University “for the faculty whose words or actions will be taken to the grave by the residents”, December 2006
• America’s Top Psychiatrists: Consumers’ Research Council of America - listed in Guide to America’s Top Psychiatrists” 2007, 2009, 2010
• Governor’s appointee to the Board of Mental Health, Mental Retardation and Substance Abuse Services, Commonwealth of Virginia (2007-2011) (2011-2015)
• Reintegration Award – Clinical Medicine Category, Lilly National Reintegration Program. Award presented for career-long service in the treatment, rehabilitation and reintegration of persons with serious mental illness, October 2009
• Distinguished Member Recognition, Indo-American Psychiatrist Association, Virginia Chapter, October 2010.
• Global Association of Physicians of Indian Origin (GAPIO): Public Service Award for fostering Indo-US collaboration in mental illness education and services, January 6, 2011, New Delhi, India
• Exemplary Psychiatrist Award: The National Alliance for the Mentally Ill, May 2011
Teaching Experience: Course Coordinator. Lectures on Psychotic Disorders for PGY-1 & PGY-2 psychiatry residents (1978-79). NIMHANS, Bangalore, India. Seminar Coordinator. Seminar series on International Pilot Study of Schizophrenia (1978). NIMHANS, Bangalore, India. Editor, “Capsule" bimonthly letter on recent developments in psychopharmacology for residents and faculty, Department of Psychiatry, SUNY, Syracuse, New York (1980-1982). Supervision of PGY-4 resident (1 per year) in research elective (1982-84). Department of Psychiatry, Columbia University, New York and New York State Psychiatric Institute, New York. Virginia Commonwealth University, Medical College of Virginia Teaching Activities (1984 - ).
Pandurangi, Ananda K
5
• Introduction to Clinical Medicine: M-I students in small groups - conjointly with a Family Practice physician (1991-97').
• Introduction to Clinical Interview: M-II students in small groups - Teaching clinical interview techniques (1984 - present).
• Clinical Training of M-III students (8-16 per year, 6 weeks each (1984 - present) • Electives for M-IV students in Schizophrenia, Biological Psychiatry and
Psychopharmacology (1-2 students per year, 4 weeks each (1984 - present) • Clinical Training of PGY-1 & 2 Psychiatry Residents in Schizophrenia and Major
Mental Illness (8-12 per year, 1984 - present) • Clinical Training of PGY-2 residents (12 per year, one month each) in the theory
and administration of ECT (1987-96, 1999 – 2001, 2002 – present, shared with Dr Allison Lynch)
• Clinical Training of PGY-3 Psychiatry Resident in outpatient management of schizophrenia and chronic mental illness (4 per year, 1984 – 90’)
• Supervision of PGY-4 residents (4 per year) in providing mental health services to homeless persons in Richmond. MCV/VCU, Richmond, Virginia (1987-1991).
• Clinical teaching of pharmacy interns (1-4 per year), doctoral psychology interns (4 per year) and graduate students in Occupational therapy (4 per year). MCV/VCU, Richmond, Virginia (1984-2002).
• Didactics to Graduate Psychiatry Trainees, MCV/VCU, Richmond, Virginia • Psychotic Disorders (PGY-1) • Phenomenology, Diagnosis and Management of Schizophrenia (PGY-2) • Neurobiology of Schizophrenia (PGY-3) • Brain Imaging in Psychiatry (PGY-3) • Advanced Psychopharmacology of Psychotic Disorders (PGY-4) • Tardive Dyskinesia and Its Management (all trainees) • Treatment Resistant Schizophrenia (all trainees) • Electroconvulsive Therapy (PGY 1 & 2; 1991-1995) • Course Moderator & Lecturer: Brain Imaging in Psychiatry (PGY-4) • Psychopharmacology of Psychosis in Pregnancy & Lactation • Integrating psychopharmacology and psychotherapy in the management of
psychoses • Treatment of Bipolar Disorders (PGY-4)) • Atypical Depression and Refractory Depression (PGY-4) • Moderator & Participant, Weekly Conferences in Inpatient Psychiatry (Case
Conference, Journal Club, Administrative Psychiatry) • Psychopharmacology: 1/2 day workshops for non-physician mental health
professional groups in Virginia (1987 –89’, 92'-94’, 00’,02’) • Psychopharmacology: Small Group discussion for M-III students(1992 –96’) • Clinical supervision of graduate social work student in Schizophrenia Clinic (1
student per year) from the School of Social Work/VCU (1985 - 87') • Didactic to social work students (MSW), School of Social Work/VCU on
Pharmacotherapy of Psychiatric Disorders (1989-91, 93'-94') • Continuing medical education Lectures to Community Physicians and
Psychiatrists in Virginia and the mid-Atlantic Region, on (i) Schizophrenia, (ii) Bipolar Disorder, (iii) Clozapine, (iv) Atypical Antipsychotics (v) ECT, TMS and
Richmond, Virginia (1985 - ). Over 4500 procedures as of June 2012. • Attending Psychiatrist, Inpatient Acute Care Specialty Teams (Crisis, Medical
Psychiatry, Geriatric Psychiatry, Schizophrenia, Mood Disorders), 3 months per year (2002-present).
• Attending Psychiatrist, TMS program (2010 - ) Also See Consulting Activities
Administrative Experience: Academic Medical Center
• Member, Research Committee, Upstate Medical Center, Department of Psychiatry, Syracuse, New York (1980-1982)
• Director, Schizophrenia Program, Medical College of Virginia, Department of Psychiatry. (1984 July - Present).
• Member, Chronic Mental Illness Training Program - Ad Hoc Committee, Medical College of Virginia, Department of Psychiatry (1985-1990).
• Interim Director (1986-1987), Inpatient Psychiatry Service, Medical College of Virginia, Richmond, Virginia.
• Member, Committee on the Conduct of Human Research, Medical College of Virginia/Virginia Commonwealth University (1988 - 1993).
• Member, Psychopharmacology Curriculum Committee, Department of Psychiatry, Medical College of Virginia (1988).
• Chief Organizer and Moderator: National symposium on schizophrenia titled "Schizophrenia: Has the Code been broken ?" Richmond, Virginia, June 1989.
• Member, Advisory Council for Training In Long Term Mental Illness -School of Social Work, Virginia Commonwealth University (1986 -1988)
• Director, ECT Services, MCV Hospitals, Virginia Commonwealth University (1990-95, 00 - ), Co-Director (1996-99)
• Interim Chairman, Division of Inpatient Psychiatry. Medical College of Virginia/VCU (December 1990-December 1991)
• Chairman, Division of Inpatient Psychiatry. Medical College of
Virginia/VCU (January 1992 - Present) – see attached organization chart
• Member, Finance Committee, MCV-Psychiatry Associates, Department of Psychiatry, MCV/VCU (1992-94).
• Board of Directors, MCV-Psychiatry Associates, Department of Psychiatry, MCV/VCU (1992, 93’, 94’, 95’).
• Chair, Promotions Committee, Department of Psychiatry, MCV/VCU, (1992-94’, 96’, 98’, 03’).
Pandurangi, Ananda K
8
• Member, Promotions Committee, Department of Psychiatry, 2007, 2009) • Member, Strategic Review Committee (Mission, Administration, Clinical Care-
Managed Care), Department of Psychiatry, MCV/VCU (1993, 1997, 2004). • Member, Managed Care Committee, Department of Psychiatry, MCV/VCU
(1994-2002) • Chair, Tenure Committee, Department of Psychiatry, MCV/VCU (1995) • Alternate, Faculty Senate, Virginia Commonwealth University(1997-98, 98-99) • Member, Promotions & Tenure Sub-Committee, Department of Internal
Medicine, VCU-MCV, 1998; Department of Psychiatry (2000) • Member, Chair Search Committee for the Department of Physical Medicine &
Rehabilitation, School of Medicine, VCU (1998-99) • Member, Mental Health Task Force, MCV Hospital Authority and VCU
Department of Psychiatry, 1999. • Member, Department of Psychiatry Senior Administrative Standing Committees
on Education, Clinical Enterprise, Finances, Strategic Development (2000 - ). • Member, Advisory Group, Center for Human-Animal Interaction, VCU School of
Medicine, (2001 - ) • *Gilmore Fellow & Faculty Mentor for the Psychiatrists in Underserved Areas
program, Contract from the Commonwealth of Virginia. Annual Amount $116,000 (2000 - 2002); Governor’s Fellow & Faculty Mentor – Annual Contract Amount $35,000, (2002-3). *Also noted under Grants & Contracts
• Member, Faculty Pay Plan Committee, Department of Psychiatry, VCU (2003) • Department Representative (alternate), HPR-IV Consortium (Consortia of
Community Service Boards), Richmond, VA (2004 - ) • Faculty Grievance Panel, Virginia Commonwealth University (2008 - ) • Director, VCU – PGIMER Partnership, VCU International Partnerships Program,
(2009 - ) • Member, VCU International Partnerships Council (2009 - ) • Vice-Chair, Department of Psychiatry, Virginia Commonwealth University
• Member, VCU India Business Plan Work Group, VCU Global Education Office (2011- )
• Member, Search committee for Chair, Division of Addictions Medicine (2012) • Member, Search Committee for Chair of Department of Neurosurgery (2012)
University Hospital Committees:
• Member, Pharmacy & Therapeutics Committee, Medical College of Virginia Hospitals, (1986 - present).
• Member, Substance Abuse Services Committee, School of Medicine & MCV Hospitals, MCV/VCU, 1993-94.
• Psychiatry Indirect Cost Review Group, MCV Hospital Authority 1995 - • Psychiatry Value Enhancement Project, MCV Hospitals 1998 - 99 • Radiology Archiving & Communication Systems Group, MCV Hospitals(1999) • Bed Allocation & Space Committee, MCV Hospitals, 2000
Pandurangi, Ananda K
9
• Root Cause Analysis Work Groups, MCV Hospitals, 2000, 2004, 2008 • Hospital Information System (CERNER), Psychiatry Liaison, MCV Hospitals
2000 • Crisis Stabilization Program Work Group (2003-2004) • Behavior Health Planning Group, VCU Health System (2006 -07) • Emergency Department – Space Planning Group (2007-2009) • Member, Community Agency Support Committee, VCU Health System, 2009-11
Public–Academic Liaison
• Member, Working Committees to establish the collaboration between Department of Psychiatry, Columbia University, New York and Creedmoor Psychiatric Center, New York (1982-84’)
• Member of working committees to enhance the collaboration between the Department of Psychiatry, Medical College of Virginia, Richmond, Virginia and Central State Hospital, Petersburg, Virginia (1986-1988).
• Chief Coordinator of the above Collaboration (1987-1989). • Coordinator of psychiatrist services, Project on Mental Health Services to the
Homeless, Richmond City Mental Health Clinic and Department of MH/MR/SA, Commonwealth of Virginia. Supported by a demonstration grant from the National Institute of Mental Health, USA (1989-91').
• Member, State Committee on Research and Clozapine. Virginia Alliance for the Mentally Ill (1990, 1991).
• Member, Department of Psychiatry Task Group for establishing collaborative and contractual relationship with Richmond Behavioral Health Authority (1997-98)
• Chief Medical Liaison, Medical Services Contract to Department of Psychiatry, VCU-MCV awarded by Richmond Behavioral Health Authority (1998- ). Contract Amount for 2008 $975,000.
• Medical Contract Liaison, Psychiatric Consultation Services, Hiram Davis Medical Center, Petersburg, Virginia, Commonwealth of Virginia (2000 - ), contract amount for 2008 $133,000.
• Medical Contract Liaison, Medical Services to Daily Planet, Not-For-Profit MH Agency for Indigent, Homeless and Underserved populations, Richmond, (2000 -2011), Virginia, annual contract amount $105,000.
• Medical Contract Liaison, Medical Services Contract, HPR-IV Sponsored Crisis Stabilization Program and Rubicon, Inc. operated Substance Abuse Services, Richmond, Virginia. (2002 - 2010), annual contract amount $140,000
• Medical Services Contract Liaison, District-19 Community Services Board, Petersburg, Virginia (2011 - )
• HPR-IV Region Public-Academic Liaison (2011 -)
Also see under State Government Activities
Consultancy & Review:
Journal Reviewer:
Pandurangi, Ananda K
10
• Acta Psychiatrica Scandinavia, American Journal of Psychiatry, Asian Journal of Psychiatry, Biological Psychiatry, Bulletin of Clinical Psychopharmacology Clinical Schizophrenia & Related Disorders, Journal of Clinical Psychiatry, Journal of Clinical Psychopharmacology Journal of Neuropsychiatry & Clinical Neuroscience, Journal of Women’s Health, Psychological Medicine, Psychosomatics, Schizophrenia Research.
• Member, International Advisory Committee, Indian Journal of Psychiatry (2008 - )
• Editorial Board, International Scholarly Research Network (ISRN) (2011 - ) • Member, Scientific Advisory Board, Bulletin of Clinical Psychopharmacology
(2012 - )
NIH Reviewer/Investigator
CSF Studies in Schizophrenia Collaborative Network (1990) Ad-Hoc Reviewer, NIMH, Classification and Nosology IRG (DSM-V
Planning Conferences (2003) Reviewer, NIH Center for Scientific Review (Biomedical Imaging
IRG) 2005-06’
Consultant/Visiting Professor:
• Consulting Psychiatrist & Clinical Psychopharmacologist for physicians in Virginia, (1985 - present). Over 1400 consultations as of June 2010.
• Consultant, Central State Hospital, Petersburg, Virginia (1985-1991, 1997 - present)
• Consultant, Hiram Davis Medical Center, Petersburg, Virginia, Commonwealth of Virginia, DMHMRSAS (2000-2006)
• Consultant, Eastern State Hospital, Williamsburg, Virginia (2003 – present) • Mail Box - The Doctor Answers: Consultation service for the Central Virginia
Alliance for the Mentally Ill (1993, 94'). • Experts Panel for Schizophrenia, Virginia Health Outcomes Program, Department
of Health Administration, Virginia Commonwealth University (1997) • Consulting Member, Scientific Program Committee, American Psychiatric
Association, Washington, DC. (2001 – 2004). Member New Research Sub-Committee (2001 – 2004)
• Consultant & Reviewer, Richmond Community Hospital Psychiatry Service (2006)
• Visiting Professor Post-Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India, (2009 - )
• Visiting Professor, SRM Medical College, Chennai, India (2012 - )
Examiner/Guide:
• Post-Doctoral (Ph.D.) examiner, School of Social Work, Virginia Commonwealth University – Rosemary Farmer, MSW (1990, 91').
• Post-doctoral (Ph.D.) examiner, Department of Psychology, Virginia Commonwealth University, Kenji Sax, MS (1992, 94').
• Member, Question Writing Committee, American Board of Psychiatry &
Pandurangi, Ananda K
11
Neurology, Part I examination in Neurology (1992 – present) • Member, Oral Examinations Committee, American Board of Psychiatry &
Neurology, Part II examination in Psychiatry (1992 – present) • Post-Doctoral (Ph.D) Advisory Committee – VCU Studies in Medical Physics
J&J), Novartis, Pfizer Pharmaceuticals (1990 – 2009) • Global Therapeutic Expert Forum, Merck Inc, 2010 • Consultant and faculty trainer for psychopathology ratings. Prophase, Inc, NY,
NY (2010 - )
Legal Consultancy:
• Malpractice Case Reviews and Expert Testimony • Expert Evaluations for Capital Punishment Cases (Capital Defense Office,
Richmond, VA) • Expert Evaluations for Schizophrenia and Related Disorders (Federal Public
Defenders Office, Richmond, VA)
State Government:
• Member of State Committee on Human Development Resources, Department of Mental Health/Mental Retardation/Substance Abuse Services, Commonwealth of Virginia (1990).
• Member, Research Advisory Council, Department of Mental Health/Mental Retardation/Substance Abuse Services, Commonwealth of Virginia (1990, 1991).
• Member of State Task Force on Clozapine, Department of Mental Health/Mental Retardation/Substance Abuse Services, Commonwealth of Virginia (1990).
• New Medications Work Group, Commonwealth of Virginia, Department of MH/MR/SAS Services (1997- )
• Physician Reviewer, Audit Team, Dept of MH/MR/SAA for Western State Hospital, Staunton, Virginia (1996)
• Invited Expert on Role of Academic Medical Centers in Public Psychiatry: Commonwealth of Virginia, Hammond Commission - Committee on Client Services, Fredricksburg, Virginia June, 1999.
Pandurangi, Ananda K
12
• Research Review Panel, (Training Grants in Substance Abuse Research), Department of Mental Health/Mental Retardation/Substance Abuse Services, Commonwealth of Virginia (1990, 1991, 1992).
• Invited participant, “Ensuring the supply of Behavioral and Mental Health Providers Summit”, Nashville, TN, sponsored by Human Services Resource Administration, SAMSHA and Appalachian Regional Commission of the U.S. Federal Government, 2001
• Member, MH/MR/SA Services Board, Commonwealth of Virginia.
Appointee of the Governor, Commonwealth of Virginia (2007 – 2015)
• MH Work Force Development Sub-Committee, Mental Health & Law Reform Commission by the Chief Justice of the Supreme Court of Virginia (2008-2009)
• Member, Selection Committee for Medical Director and Assistant Commissioner for Quality Assurance, Department of Behavior Health and Developmental Services, Commonwealth of Virginia (June 2011)
Professional Societies & Related
• Psychiatric Society of Virginia, Member, Program Committee,: 1986-88. • Psychiatric Society of Virginia, Chair, Program Committee, (1991,92,93). • American Psychiatric Association – DSM-IV Task Force, Psychotic Disorders
Work Group (1992-93) • American Psychiatric Association – Consultant, New Research Section, Annual
Meeting of APA (2000-04) • President, American Association of Psychiatrists From India, Virginia Chapter
2006), Executive Council Member (2005 - 2007), Distinguished Academician Award Committee (2005, 06’, 07’, 08’)
• Indian Psychiatric Society. Scientific Program Liaison to Annual Conference of the Indian Psychiatric Society (2006, 07’)
• Co-chair, Indo-US Health Care Summit, Mental Health Section, sponsored by the American Association of Physicians From India, Government of India, Medical Council of India, and the Indian Medical Association (2007-08’).
• Chair, Indo-US Health Care Summit (Global Summit), Mental Health Section, sponsored by the American Association of Physicians from India (AAPI), Government of India, Medical Council of India (MCI), and the Indian Medical Association (IMA) (2007, 2009, 2010).
• Member, Indo-Global Psychiatric Initiative Council (2010 - ) • Chair, Global Health Summit, Mental Health Section, sponsored by the Global
Association of Physicians of Indian Origin (GAPIO), 2011, 2012. • Secretary, Psychiatric Society of Virginia, State Branch of American Psychiatric
Association (2011-2012) • Member/Director, MCV Physicians Governing Board, Virginia
Commonwealth University Health System (2011-2014)
• Member, Committee on Public Relations and Communications, MCV Physicians, VCU Health System (2011-2014)
Pandurangi, Ananda K
13
Grants & Contracts: Principal Investigator: 1. Stipendee, NIMH, Post-doctoral Fellowship Training Grant to Columbia University, Department of Psychiatry, New York, New York: (1982-84) 2. Principal Investigator, Project Title:"Familial and Sporadic subtypes of Schizophrenia; A.D. Williams Research Grant, Medical College of Virginia, Richmond, Virginia. $8600/-, (1984-85) 3. Principal Investigator, Project title: Labelled Dopamine uptake by platelets in healthy volunteers and schizophrenic subjects. Virginia Commonwealth University - Faculty Grant-in-Aid. $5,000.00/-, (1985-86). 4. Principal Investigator: Project title: Labelled Dopamine uptake by platelets and Magnetic Resonance Imaging in Schizophrenia. Biomedical Support Grant (NIH), Medical College of Virginia, Richmond, Virginia. $4600/-, (1986-87). 5. Principal Investigator, Project title: Serum Molindone Levels and Treatment of Psychosis. Educational Support grant from Dupont Nemours, Inc., Delaware. $1300/-, (1986-87). 6. Principal Investigator, Project title: Bio-Behavioral Heterogeneity in Schizophrenia. FIRST Award, National Institute of Mental Health (PHS). Total cost $ 232000/-, 1989-92. 7. Principal Investigator, Project title: Schizophrenia Program Development & Medical Management during Clozapine Treatment, Sandoz Pharmaceuticals, E. Hanover, New Jersey. Program Development Grant, $8,000/-, 1990-91, 8. Principal Investigator, MCV-VCU site: Study of EM 62-100-004 (Roxindole), a potential antidepressant/antipsychotic compound - A phase II, multicenter, randomized, paralell group, double blind, dose finding study of Roxindole vs Placebo". E.Merck Industries, Hawthorne, New York and Darmstadt, Germany. Total Cost $106,000/-, (1992-93). 9. Awardee, State Council on Higher Education in Virginia, Equipment Grant for Brain Imaging (1992) $28000/- 10. Prinicipal Investigator, MCV-VCU site: RIS-63-USA "A Randomized, Double Blind, Placebo Controlled Study of Risperidone for the Treatment of Psychosis and Behavioral Disturbances in Subjects with Dementia". Victor Vieweg, M.D., Co-Principal Investigator. Janssen Research Foundation, Titusville, New Jersey, $156,000/- (1995). 11. Project Director: Crisis Stabilization and Residential Program, MCV Hospitals, Richmond, Virginia. Contract with City of Richmond, Community Services Board,
Pandurangi, Ananda K
14
$285,000/- per annum (1995, 1996, 1997). 12. Principal Investigator, MCV-VCU site: A Multicenter, Open, Randomized Comparison of ICI 204634 (Seroquel) and Usual Care on Health Outcomes in Subjects with Schizophrenia and Schizoaffective Disorder. Zeneca Pharmaceuticals, Wilmington, Delaware. Total cost $114,276/- (1996-97). 13. Principal Investigator: RIS-70-USA "An Open Label Long Term Study of Risperidone for Treatment of Behavioral Disturbances in Subjects with Dementia". Victor Vieweg, M.D., Co-Principal Investigator. Janssen Research Foundation, Titusville, New Jersey. Total Cost $116,880/- (1996-97). 14. Principal Investigator, MCV-VCU site: RIS-USA-112 & 113. Studies Comparing Olanzapine and Risperidone in the treatment of schizophrenia. Janssen Research Foundation, Titusville, NJ. Total Cost $120,000(97-99’)
15. Principal Investigator, MCV-VCU site: RIS-USA-121 & 196. Risperidone Long Acting Depot Injection in the Treatment of Schizophrenia. Janssen Pharmaceutica and Research Foundation, Titusville, New Jersey. Total Cost $200,000 (1999- ). 16. Equipment Grant for Trans-cranial Magnetic Stimulation Therapy Program. Medical College of Virginia Hospital Authority, Richmond, Virginia. Total Cost $28,000 (2000). 17. Principal Investigator, MCV-VCU Site: RIS-240 & 241. Risperidone in Bipolar Mania and Mixed Manic State – Double Blind Placebo Controlled Comparator Study and Open-label Extension study. Janssen Pharmaceutica & Research foundation, Titusville, NJ (2001) 18. *Project Director, VCU, Department of Psychiatry: Psychiatrists In Underserved Areas Program, Commonwealth of Virginia. $116,000 (2000 – 02’) & $40,000 (02’-04’) – *Also noted under Academic Medical Center, Public-Academic Liaison Activities 19. Principal Investigator, MCV-VCU site: RIS-USA-259 & 265. Risperidone Long Acting Depot Injection in the Treatment of Schizophrenia. Janssen Pharmaceutica and Research Foundation, Titusville, New Jersey. Total Cost $200,000 (2002 –04’ ).
20. Principal Investigator, MCV-VCU Site: CNS 012 & 013. Aripiprazole Injection for the Treatment of Agitation in Schizophrenia, Schizoaffective Disorder (CN-012) and Bipolar Manic and Mixed Disorder (CN-013), Bristol Myers Squibb, Wallingford, CT, $200,000 (2004 –05) 21. Principal Investigator, VCU Site: Treatment Resistant Depression Registry and Vagus Nerve Stimulation. Cyberonics, Houston, Tx, $35000 annually (2005-2009) 22. Principal Investigator, VCU Site: Predicting Response to Risperidone Treatment Through Identification of Early-Onset of Antipsychotic Drug Action in Schizophrenia (F1D-US-HGMN(a)). Sponsor Eli Lilly & Co, Indianapolis, IN. $159,505 (2006 – 2007).
Pandurangi, Ananda K
15
(24) Principal Investigator: Brain Imaging pre- & post TMS Therapy. MCV Foundation Funds, Richmond, VA, $15000 (2006 - 2008) (25) Co-P.I, VCU-PGI, Chandigarh, India, Teaching Collaboration, Teaching & Travel Grant (with Dr Joel J Silverman), $6000. Office of International Education, Virginia Commonwealth University, 2009 (26) Principal Investigator, VCU Site: Deep Brain Stimulation for Refractory Depression- Acute and Long Term Follow-up Studies. Sponsor: St Jude Medical, Plano, Texas. Total Cost $1,041,000 (2010-2015) (27) Principal Investigator, VCU Site: Multi-center trials of the mgluR agonist LY 2140023 in the treatment of schizophrenia (3-related studies titled HBBN, HBBO & HBDE). Total cost $1,800,000 (2011-2014) (28) Principal Investigator, VCU-PGIMER Collaborative Project on Psychiatric Education for Medical Students, Global Education Office, Virginia Commonwealth University, $30,000 (2011-2012) Co-Investigator:
1. Research Fellow: Project Title: Computed Tomographic Findings In Schizophrenia; Mental Illness Research Foundation, New York State. Principal Investigator: Ronald O. Rieder, M.D. $25,000/-, (1982-84) 2. Co-Investigator, Training Program in Chronic Mental Illness. National Institutes of Mental Health (PHS) Teaching Grant. Principal Investigator J.J. Silverman, M.D. $360,000.00 (1985-1988). 3. Co-Investigator and Site Coordinator: DSM-IV Field Trials for Psychotic Disorders - NIMH grant to the American Psychiatric Association. Allen Frances P.I., (1990-92) Site contract: $14,000/- 4. Co-Investigator, m-CPP challenge in Schizophrenia - grant by the Scottish Rite Foundation to Dr Adityanjee at MCV/VCU, $70,000/-, 1993-94. 5. Co-Investigator, Acute and Convalescent Serum Antibody Titers to Herpes Virus - grant by the Stanley Foundation to Dr Anthony Pelonero at MCV/VCU, $15000/-, 1994. 6. Co-Investigator, MCV-VCU Site, Incidence of Tardive Dyskinesia in Elderly Patients Treated with Olanzapine. P.I. Victor W. Vieweg, M.D., Sponsor: Eli Lilly Research, Total Cost $232,000 (1998) – Note: Study was not completed due to problems at the clinical site.
BIBLIOGRAPHY:
Pandurangi, Ananda K
16
Articles & Book Chapters: (1) Pandurangi AK, Ananth J, Channabassavanna SM: Tardive Dyskinesia in an
Indian Mental Hospital: Indian J Psychiat, 1978, 20, 339-342. (2) Kapur RL, Pandurangi AK: A Comparative Study of Reactive Psychosis and
Acute Onset Psychosis without Antecedent Stress: Brit J Psychiat, 1979, 135, 544-550.
Psychiat Scand, 1980, 61, 89-95. (4) Pandurangi AK, Vasundhara Devi, Channabassavanna SM: Caudate Nucleus Atrophy in Irreversible Tardive Dyskinesia- A Pneumoencephalographic Study: J Clin Psychiat, 1980, 41, 7-10. (5) Dewan MK, Pandurangi AK, Major L et al: Abnormal Dexamethasone
Suppression Test in Nondepressed Chronic Schizophrenics: Am J Psychiat, 1982, 139, 1501-1503.
(6) Deveaugh-Geiss J, Pandurangi AK: Confusional Paranoid Psychoses after
Withdrawal from Sympathomimetic Amines: Am J Psychiat, 1982, 139, 1190-91. (7) Dewan MK, Pandurangi AK, Lee SH et al: Central-Diencephalic Morphology in
Chronic Schizophrenia - A Computerized Tomographic Study: Biol Psychiat, 1983, v 18, n 10, p 1133-1140.
(8) Pandurangi AK, Dewan MK, Lee SH et al: The Ventricular System in Chronic
Schizophrenia - A Computerized Tomographic Study: Brit J Psychiat, 1984, 144, 2, 172-176.
(9) Devanand DP, Pandurangi AK, Dewan MK: Abnormal DST following
Neuroleptic Withdrawal – Case Report: J of Clin Psychiat, 1984, 45, 6, 275-276. (10) Dewan MK, Pandurangi AK, Lee at al: Cerebellar Abnormalities In Chronic
Schizophrenic Patients - A Computerized Tomographic Study: Psychiatry Res, 1983, v 10, n 2, p 97-103.
(13) Pandurangi AK, Dewan MJ, Lee SH et al: EEG, Biochemical and
Neuropsychological Correlates of CT Normal and Abnormal Schizophrenics - Acta Psychiat Scand, 1986, 73, 161-170.
(14) Dewan MJ, Pandurangi AK, Levy BF et al: Are Schizophrenics with Abnormal
DST Results a Distinct Subgroup? Acta Psychiat Scand, 1985, 72, 274-277. (15) Pandurangi AK: On Schizophrenia: Light At the End of the Tunnel. Virginia
Medical Monthly, 1986, July, 113, 7, 406-407. (16) Boucher ML, Dewan MJ, Donnelly P, Pandurangi AK et al: Relative Utility of
Three Indices of Neuropsychological Impairment in a Young, Chronic Schizophrenic Population. J Nervous Mental Disorder, 174, 1, 44, 1986.
In Disorders of Movement in Psychiatry and Neurology. Editors: Joseph A.B., Young R.R.,1st edition 1992, Chapter 16, pages 125-133, 2nd edition 1997, Blackwell Scientific Publications, Cambridge, MA.
Positive Formal Thought Disorder in Schizophrenia. Schizophrenia Research. 13, 1994, 109-116.
(31) The DSM-IV Schizophrenia and Other Psychotic Disorders Field Trial Group:
The DSM-IV Field Trial For Schizophrenia and Other Psychotic Disorders. DSM-IV SOURCEBOOK, Vol 4, 687-716, 1998, American Psychiatric Association, Washington, D.C.
(32) Vieweg V, Pandurangi, A, Levenson, J and Silverman, J: The Consulting
Psychiatrist and The Polydipsia-Hyponatremia Syndrome in Schizophrenia. The International Journal of Pschiatry in Medicine, 24, 1994, 275-303.
(33) *Pandurangi, A.K.,: Schizophrenia in DSM-IV and Implications for Biological
Psychiatry Research, Methods in Biological Psychiatry, (eds)S. Khanna, Channabasavanna, S.M., & Keshavan, M.S., Chapter 1, pages 1-9, 1995, New Delhi India, Tata-McGraw Hill Publications.
(34) *Pandurangi, A.K.,: Structural Brain Imaging In Schizophrenia. In Methods in
Biological Psychiatry, (eds) S Khanna, Channabasavanna, S.M., & Keshavan, M.S, chapter 4, pages 32-40, 1995, New Delhi, India, Tata-McGraw Hill Publications.
(35) Vieweg, V., Levenson, J., Pandurangi, A., Silverman, J.: Medical Disorders in
the Schizophrenic Patient. The International Journal of Psychiatry in Medicine. 25 (2) 135-170, 1995
Pandurangi, Ananda K
19
(36) Pandurangi, AK, Aderibigbe, Y: Tardive Dyskinesia - An International Survey of Epidemiological Studies. European Archives of Clinical Neuroscience, 246, 47-52, 1995
and obesity in children and adolescents: How Should We Assess Drug-associated Weight Gain? Acta Psychiatr Scand. 2005, 111, 177-184.
(53) W. Victor R. Vieweg, A. Bela Sood, Anand K. Pandurangi, Joel J. Silverman:
Application Of Body Mass Index Principles In A Model Elementary School: Implications For Overweight And Obese Children: Journal of the National Medical Association, 2004, 96, 4, 468-475
(54) W. Victor R. Vieweg, A. Bela Sood, Anand Pandurangi, Joel J. Silverman: Choose precise BMI charts to track youth’ weight gain: Current Psychiatry, Vol 3, No 10, October 2004
Sood B, Silverman, JJ: Body Image and Attitude Toward Obesity in an Historically Black University. J National Med Assoc, V 97, No 2, February 2005, 225-36
(56) Ose, BL, Pandurangi, AK: Delusional Wife: A Case of Diagnostic Ambiguity and
Treatment Challenge. J Psychiat Pract, May 2005, Vol 11, No 3, 1-8. (57) W. Victor R. Vieweg, Lisa J. Kuhnley, E. John Kuhnley, Emmanuel A. Anum,
A. Bela Sood, Anand Pandurangi, Joel J. Silverman: Body mass index (BMI) in newly admitted child and adolescent psychiatric inpatients. Prog Neuropsychopharm Biol Psychiat, 2005, 29, 511-515
(58) W. Victor R. Vieweg, Maxcine Maxfield, Robert E. Lewis, Brigitte Pennington,
Anand Pandurangi, Joel J. Silverman: Direct-care staff body mass index in a state mental hospital. Staff obesity may impair role modeling for patients. Progress in Neuro-Psychopharmacology & Biological Psychiatry (2005), 29, 989-991
Pandurangi, Ananda K
21
(59) Vieweg WV, Linker JA, Anum EA, Turf E, Pandurangi AK, Sood B, Fierro MF, Fernandez A. Child and adolescent suicides in Virginia: 1987 to 2003. J Child Adolesc Psychopharmacol. 2005 Aug;15(4):655-63.
(60) W. Victor R. Vieweg, Anand K. Pandurangi, Emmanuel A. Anum, Jack O. Lanier, Marcella F. Fierro, Antony Fernandez: Toxicology findings in child and adolescent suicides in Virginia: Prim Care Companion J Clin Psychiatry, 2006, 8, (3), 142-146
(61) W. Victor R. Vieweg, Demetrios A. Julius, Antony Fernandez, John M. Hettema,
Anand K. Pandurangi: Posttraumatic stress disorder - Clinical features, Pathophysiology, and Treatment, American Journal of Medicine, 2006, 119, 383-390
(62) Vieweg WV, Julius DA, Fernandez A, Levy JR, Satterwhite L, Benesek J, Feuer
SJ, Pandurangi,AK: Posttraumatic stress disorder and body mass index in military veterans: The Richmond experience. Stress, Trauma, and Crisis:2006, 9, 17-28
(63) Vieweg WV, Pandurangi AK: The Relation of Stress and Psychiatric Illnesses to Heart Disease. Acta Psychiat Scand, 2006, 1-4 (Invited Editorial).
(64) Vieweg WV, Julius DA, Fernandez A, Tassone DM, Narla SN, Pandurangi AK: PTSD in Male Veterans with Comorbid Overweight and Obesity: Psychotropic, Antihypertensive, and Metabolic medications. Primary Care Companion J Clin Psychiat. 2006, 8:25-31
(65) Vieweg WV, Fernandez A, Julius DA, Satterwhite Pandurangi AK: Body Mass
Index relates to Priority Group in Department of Veterans Affairs’ Male Veterans with PTSD. The Richmond Experience. J Nat Med Assn, 2006, 98, 4, 580-586
(66) Vieweg WVR, Julius DA, Benesek J, Satterwhite L, Fernandez A, Feuer SJ, Pandurangi, AK: PTSD and BMI in Military Veterans – Preliminary Findings. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 2006, 30, 1150-1154
(67) Zhang, W, A. Pandurangi, and K. Peace: YinYang Dynamic Neurological Modeling and Diagnostic Analysis of Major Depressive and Bipolar Disorders. IEEE Trans Biomed Eng, 2007 Oct;54(10):1729-39.
(68) Vieweg, VWR, Johnston CH, Lanier JO, Fernandez A, Pandurangi AK: “Correlation between High Risk Obesity Groups and Low Socioeconomic Status in School Children”, Southern Med Journal, 2007, v 100, 1, 8-13
(69) Lynch AM, Pandurangi AK, Levenson JL: Electroconvulsive Therapy in a
Pandurangi, Ananda K
22
candidate for heart transplant with an Implantable Cardiovertor Defibrillator and Cardiac Contractility Modulator". Psychosomatics, 2008, 49;4, July-August
(70) Vieweg WV, Julius DA, Fernandez A, Wulsin IR, Mohanty PK, Neatty-Brooks
M, Hasnain M, Pandurangi, AK. Treatment of depression in patients with coronary heart disease. Am J Med. 2006 Jul;119(7):567-73.
(71) W. Victor R. Vieweg, Julius DA, Bates J, Quinn JF 3rd, Fernandez A, Hasnain
M, Pandurangi, AK: Posttraumatic stress disorder as a risk factor for obesity among male military veterans. Acta Psychiatr Scand. 2007 Dec;116(6):483-7.
(72) Hasnain M, Vieweg W. V, Hettema JM, Colton D, Fernandez A, Pandurangi AK:
“The risk of overweight in children and adolescents with major mental illness". Southern Medical Journal, 2008, 101, 4, 367-372.
(73) Vieweg WV, Levy JR, Fredrickson SK, Beatty-Brooks M, Fernandez A, MD,
Hasnain M, Pandurangi, AK: Psychotropic drug considerations in depressed patients with metabolic disturbances. Am J Medicine, 2008, 121, 647-655
Chapter 31, pp 380-389. In Secondary Schizophrenia. (Eds) Sachdev P, Keshavan MS., 2010, Cambridge University Press, Cambridge, UK
(75) Pandurangi, AK, A Dalkilic: Atypical Polypharmacy - A Review of Evidence.
J Psychiat. Pract. 2008, v14, n6, 345-367 (76) Trutia A, Bledowski, J, Pandurangi AK, Kahn D: Neuroleptic Rechallenge with
Aripiprazole in a Patient with Previously Documented Neuroleptic Malignant Syndrome. J Psychiat Pract, 2008, v14, n6, 398-402
(77) M Hasnain, Vieweg WVR, Fernandez, Fredrickson, S, Beatty-Brooks M,
Pandurangi, AK: Clinical Monitoring and Management of the Metabolic Syndrome in Patients Receiving Atypical Antipsychotic Medications. Primary Care Diabetes, 2009 Feb;3 (1):5-15. Epub 2008 Dec 10
(78) Hasnain M, Vieweg WVR, Baron MS, Beatty-Brooks, M, Fernandez A,
Pandurangi, AK; Management of Psychosis in Elderly Patients with Parkinsonism. The Role of Atypical Antipsychotics and Cholinesterase Inhibitors. Am. J. Medicine, 2009, 122, 7, 614-622
Exploratory study of stress response patterns to interaction with a therapy dog Anthrozoos, 2010, 93, 1, 79-91. (80) Vieweg, WVR, Wood, M.A, Fernandez, A., Beatty-Brooks, M, Hasnain, M and
Pandurangi, Ananda K
23
Pandurangi, A.K.: Proarrhythmic Risk with Antipsychotic and Antidepressant Drugs - Implications in the Elderly. Drugs Aging 2009; 26 (12): 1-16
(81) Pandurangi, AK, Desai NG: Report of the 2nd Indo-US Health Care Summit. Indian J. Psychiat., 2009, 51, 4, 228
(82) Vieweg, WVR, Hasnain, M, Lesnefsky E, Turf, E, Pandurangi, AK: Assessing the
Presence and Severity of Depression in Subjects with Comorbid Coronary Heart Disease. Am. J. Medicine, 2010, 123, 683-690
(83) *Pandurangi, AK,: Psychosis Management in the Hospital. Book chapter in
Textbook of Principles and Practice of Hospital Medicine, (Eds) McKean, S, Ross, J, Dressler, D, Ginsberg, J. and Brotman, D: Burr Ridge, IL, McGraw-Hill Professional Publishing. In Press.
(84) Hasnain, M, Fredrickson, SK, Vieweg, WVR, Pandurangi, AK: Metabolic
Syndrome Associated with Schizophrenia and Atypical Antipsychotics. Curr Diab Rep (2010) 10:209 –216.
(85) Zhang W, Pandurangi, AK, Peace, KE, Zhang Y, Zhongming, Z.: MentalSquares - A Generic Bipolar Support Vector Machine (BSVM) for Mental Disorder Classification, Diagnostic Analysis and Neurobiological Data Mining, Int. J. Data Mining Bioinform. 2011;5(5):532-57. PMID: 22145533
(86) Pandurangi, AK: Indian-American Contributions to Psychiatry Research. Ind. J. Psychiat, 2010, 52, 1, S47-S55.
(87) Hasnain, M, Vieweg VWR, Pandurangi, AK, Lesnefsky, E: Title: Depression screening in patients with coronary heart disease: A Critical Evaluation of the AHA Guidelines. Journal of Psychosomatic Research. 2011 Jul;71(1):6-12. Epub 2010 Dec 16. PMID: 21665006
(88) *Pandurangi, AK: Psychiatric Training in the USA – Relevance to India, in
Psychiatric Training in India. Editor TSS Rao. Mednow Publications, Mysore, India 2011
(89) Vieweg WVR, Hasnain, M, Lesnefsky E, Pandurangi, AK: Review of major
measuring instruments in comorbid depression and coronary heart disease. Prog Neuro-Psychopharmacol Biol Psychiatry (2011), 35 (2011) 905-912 doi:10.1016/j.pnpbp.2011.03.009
Pandurangi, Ananda K
24
(90) Pandurangi, AK, Bledowski J, Fernicola-Bledwoski, C: Brain Stimulation Therapies for Psychiatric Disorders: The First Decade of the New Millennium - A Review. Asian J Psychiat, 2012, 5, 3-10.
(91) Vieweg WV, Hasnain M, Mezuk B, Levy JR, Lesnefsky EJ, Pandurangi AK
Depression, Stress, and Heart Disease in Earthquakes and Takotsubo Cardiomyopathy. Am J Med. 2011 Jun 21.PMID:21700267 (92) Vieweg WV, Hasnain M, Hettema J, Holland, Pandurangi, AK: In Press.
Citalopram, QTc interval prolongation, and torsade de pointes: How should we apply the recent FDA ruling? Am J. Med.
(93) Pandurangi, AK, Fernandez, A, Srinivasaraghavan, J: Mental Health Services in
USA: Policies and Programs - What India can Learn from Western Models: In Press, in Mental Health in South Asia – Ethical, Legal and Allied Issues. Editors: Trivedi, JK, Tripathi, A: Springer Publsihing, Amsterdam, Netherlands
(94) Srinivasaraghavan, J, Fernandez, A, Pandurangi, AK: Mental Health Services in
USA: Ethical and Legal Aspects, and Human Rights - What India can Learn from Western Models: In Press in Mental Health in South Asia – Ethical, Legal and Allied Issues. Editors: Trivedi, JK, Tripathi, A: Springer Publishing, Amsterdam, Netherlands
*Book Chapter
Letters, Abstracts/Posters, Reviews & Multicenter Study Articles: (1) Pandurangi AK, Ananth J, Channabasavanna SM: Prevalence and Etiology of
Tardive Dyskinesia in an Inpatient Mental Hospital Population. Indian Psychiatric Society Annual Meeting Abstracts, 1977, page 49, New Delhi,India.
(2) Narayan HS, Mallikarjuniah M, Pandurangi AK: Pathological Grief Reactions.
Indian Psychiatric Society Annual Meeting Abstracts, 1978, Calcutta, India. (3) Pandurangi AK, Channabasavanna SM: Phenomenology of Tardive Dyskinesia.
Indian Psychiatric Society Annual Meeting Abstracts, 1979, Pune, India. (4) Dewan M.J., Pandurangi AK, Major L: "DST in Schizophrenia" (ltr) Am J
Psychiat, 140, 1101, 1983. (5) Deveaugh-Geiss J, Pandurangi AK: Effects of d-amphetamine withdrawal in rats
and man. (ltr) Am J. Psychiat, 140, 954, 1983. (6) Dewan MJ, Pandurangi AK, Major L: "Abnormal DST results in Schizophrenia."
(ltr) Am J Psychiat, 140, 818, 1983.
Pandurangi, Ananda K
25
(7) Dewan MJ, Pandurangi AK, Major L: Abnormal DST results in patients with
Deterioration in Patients with Chronic Schizophrenia. Indian Psychiatric Society, Annual Meeting Abstracts, page 8, 1982, Jaipur, India.
(14) Pandurangi AK, Dewan MJ, Lee SH, Ramachandran T, Levy B, Boucher M,
Yozawitz A, Major L: Studies with Brain Imaging in Chronic Schizophrenics. Digest Neuro Psychiat, p. 37 and 186, 1986.
(15) Pandurangi AK, Dewan MJ, Lee SH, Ramachandran T , Levy B, Boucher M,
Yozawitz A, Major L: A Comprehensive Study of Chronic Schizophrenic Patients Parts I and II. Digest Neuro Psychiat, Part I p. 228; Part II p.229, 1986.
(16) Ochs AL, Ross DE, Goldberg SC, Pandurangi AK, Hill MR,: Predictive Slow
(17) Pandurangi AK, Goldberg SC, Brink DD, Hill M, Gulati AN: Amphetamine
Challenge Test and Lateral Ventricular Size In Schizophrenia. Society of Biological Psychiatry, Annual Meeting Abstracts, 1987, page 136.
(18) Nedathur Chari, Pandurangi AK, Landa BS: A simple HPLC Method For The
Quantitation of Molindone In Human Plasma Or Serum. Society of Biological Psychiatry, Annual Meeting Abstracts, 1987, page 104.
Pandurangi, Ananda K
26
(19) Pandurangi AK, Goldberg SC, Brink DD, Hill MH, Hart RP, Gulati AN, Hamer
RM: Amphetamine Challenge, Treatment Response and Lateral Ventricular Size In Schizophrenia. International Congress on Schizophrenia Research, Poster presentation, 1987.
(20) Pandurangi AK, Narasimhachari N: Molindone Toxicity - A Case of
Rhabdomyolysis. (ltr) J. Clin of Psychiat.49, 37-38, 1988. (21) Pelonero AL, Pandurangi AK: Re-evaluation of chronically ill psychiatric
patients. (ltr) J. Clin. Psychiatry 413, October, 1988. (22) Pandurangi AK, Pelonero AL: A Comparative Trial of Pharmacologic Strategies
in Schizophrenia. (ltr) Am J Psychiatry, 145, 7, 900-901, 1988. (23) Pandurangi AK, Bilder RM: Letter; The Symptoms of Chronic Schizophrenia.
(ltr) British J. Psychiatry, 152, 127, 1988. (24) Pandurangi AK, Goldberg SC, Ross D, Ochs AL, Brink DD, Hill MH: Biological
Markers of Positive And Negative Syndromes.American Psychiatric Association, Annual Meeting New Research Abstracts, 1988, Page 59.
(25) Nakatsuka M, O'Shanick GJ, Colenda CC, Pandurangi AK,:Changes In Cardiac
Output During Electroconvulsive Therapy. Anaesthesia Analgesia, 1989; 68:S1-S321, Abstracts, S208.
in Schizophrenia. Schizophrenia Research special issue 2:127, 1989. Poster Abstract presented at the International Congress on Schizophrenia Research, 4/89.
Seropositive Schizophrenia. CME Syllabus and Proceedings Summary, Symposium on "Viruses, Immunity and Schizophrenia", American Psychiatric Association Meeting, New York, NY 5/90, pp. 201-202.
Pandurangi, Ananda K
27
(31) Pandurangi, AK, Pelonero AL, Narasimhachari, Nedathur: Role of Serotonin in
Schizophrenia. Poster Abstract presented at the American Psychiatric Association Meeting, 5/91 New Orleans, LA.
Time (T2) in Schizophrenia." Poster Abstract presented at the International Congress on Schizophrenia, 4/91. Schizophrenia Research, special issue, 1991, page 408.
(33) Pelonero AL, Pandurangi AK: "Immunoblotting to HSV in Schizophrenia."
Poster Abstract presented at the International Congress on Schizophrenia, San Diego, CA. 4/91.
(34) Pandurangi AK, Pelonero AL, Narasimhachari N: "Serotonin in Schizophrenia."
New Research Poster Abstract, Presented at the American Psychiatric Association, May 15, 1991 in New Orleans, LA
Flow During Electroconvulsive Therapy." Abstract. Presented at the World Congress of Anesthesiology. June 12th - 19th, 1992, Hague, The Netherlands.
(36) Pelonero, AL, Pandurangi, AK: An Untoward side effect of clozapine. Ltr. J.
Nervous & Mental Disease, 1992, 536. (37) Pandurangi AK: Problems in Differential Diagnosis: From DSM-III to DSM-III-R
in Clinical Practice, by Andrew E. Skodol, M.D. Washington D.C., American Psychiatric Press, 1989 - Book review, Am. J. Psychiat, 1992, 149, 10, 1402-1403.
Response To Electroconvulsive Therapy. "Abstract. Proceedings of the 7th International Symposium, Institute of Applied Physiology & Medicine, Seattle, Washington, page 31, 1993. February 6-10, Lake Buena Vista, Florida.
in Schizophrenia. Poster presented at the International Schizophrenia Research Congress, Colorado Springs, Colorado, Schizophrenia Research, 1993, 9, 2.3, page 107.
(40) Pelonero, AL, Pandurangi, AK: Systematized Treatment in Schizophrenia. Poster
presented at the 146th annual meeting of the American Psychiatric Association in San Francisco, CA, May 26, 1993. New Research Program and Abstracts, APA, p 195.
(41) Farmer, R, Pandurangi, A: Brain Impairment and Adaptation in Schizophrenia.
Pandurangi, Ananda K
28
New Research Abstracts, 147th Annual Meeting of the American Psychiatric Association, pages 141-142. Poster presented at the same meeting in Philadelphia, PA, 1994.
(44) Habib, A, Pandurangi, A.K.,: Electroconvulsive Therapy: Efficacy and Safety.
Presented at the Eighth Annual Meeting of the Southern Association for Research in Psychiatry, New Orleans, March 25, 1995.
(45) Pandurangi A.K., Sax K, Ochs A.L., Thacker L: Ventricle Size and the Three
Syndromes in Schizophrenia. Fourth International Congress of Schizophrenia Research, Hot Springs, Virginia, April 8-12th, 1995.
Pandurangi, A.K., Robinson, D, Tohen, M.: Schizophrenia, Season of Birth, and Phenomenological Features. Schizophrenia Research, April 1995, Special Issue, Page 14. Poster presented at the International Congress of Schizophrenia Research, Hot Springs, VA, 1995.
Robinson, D, Tohen, M: Gender Differences in Schizophrenia: Findings From the DSM-IV Field Trials. Schizophrenia Research, April 1995, Special Issue, Page 16. Poster presented at the International Congress of Schizophrenia Research, Hot Springs, VA, 1995.
Tohen, M: Racial Differences in the Expression of Psychosis. Schizophrenia Research, April 1995, Special Issue, Page 21. Poster presented at the International Congress of Schizophrenia Research, Hot Springs, VA, 1995.
(49) Adityanjee, Pandurangi, A.K., Pelonero, A.L.: m-CPP Challenge Response as
Predictor of Response to Clozapine in Neuroleptic Resistant Schizophrenic Patients. Schizophrenia Research, April 1995, Special Issue, Page 141.
(50) Farmer, R., Pandurangi, A.K., Laine, F.: Brain Changes and Psychosocial
Adaptation in Schizophrenia. Schizophrenia Research, April 1995, Special Issue, Page 215. Poster presented at the International Congress of Schizophrenia Research, Hot Springs, VA, 1995.
(51) Pandurangi, A.K., Thacker, L: Response to Amphetamine Challenge and the
Three Dimensions Hypothesis of Schizophrenia. Presented at the V International Congress of Schizophrenia Research, Colorado Springs, Colorado. Schizophrenia Research, Special Issue, April, 1997.
treatments in Bipolar and Schizoaffective Disorder: Comparison of Risperidone, Conventional Neuroleptics, or Clonazepam with Mood Stabilizers. Poster presentation at the annual American Psychiatric Association meeting, San Diego, California 1997.
(54) Pandurangi, AK: Heterogeneity of Schizophrenia Addressed by Atypical
Antipsychotics. International Medical News Group Publications, December 1998. (55) Ochs, AL, Ross, AK, Pandurangi, AK, Compton, AD: Effects of Antipsychotic
Medication on Smooth Pursuit Eye Movements in Patients with Schizophrenia. Poster presentation, Int. Congress of Schizophrenia Research, Santa Fe, NM, April 1999. Abstracted in Schizophrenia Research,
(56) Pelonero AL, Levenson, JL, Pandurangi, AK: NMS and HIV (letter). In response
to letter by Horvath et al, psychiatric Services, 1999, 50, #4, page 564. (57) Katz et al for the Risperidone Study Group: Comparison of Risperidone and
Placebo for Psychosis and Behavioral Disturbances Associated with Dementia: A randomized, Double Blind Trial. J. Clin. Psychiat, 60; 2, 107-115, 1999
(58) Conley RR & Mahmoud R and the Risperidone Study Group: Risperidone Versus
Olanzapine in Patients with Schizophrenia and Schizoaffective Disorder. Presented at ICNP, Paris, October 1998
(59) Shrikhande S, Pandurangi, AK: New Antipsychotic Drugs – How are They
Different and Are They Better? Presented at the Annual National Conference of the Indian Psychiatry Society, Hyderabad, India, January, 2003
(60) Pandurangi, AK: Book Review in Psychological Medicine, 34, 175-177, 2004
– Personal Therapy for Schizophrenia and Related Disorders: A Guide to Individualized Treatment by G.E. Hogarty, Guilford Press, New York, 2002
(61) Vieweg WVR, Pandurangi, AK: Invited Comments on the Paper “Body Weight Gain Induced By The Newer Antipsychotics: An Improvement In Negative Symptoms Reversed It. – Acta Psychiat Scand, 2005, 1-1
(62) Lakhani S, Pandurangi, AK, Wallace N, Revercomb, A, Marrow, B, Lewis R,
Vieweg WVR: Geropsychiatry Clinical Database: How Can It Inform US On Morbidity Patterns? Poster Presentation, New Research Abstracts pages 240-241, APA Annual Meeting, May 25 2005, Atlanta, GA
(63) Trutia AE, Pandurangi, AK: Dual Diagnoses in Acute Care Psychiatry:
Patterns of Co-Morbidity. Poster Presentation , New Research Abstracts pages 52-53, APA Annual Meeting, May 23 2005, Atlanta, GA
Pandurangi, Ananda K
30
(64) Pandurangi, AK: Transcranial Magnetic Stimulation In Psychiatric
Disorders. Oral Paper Presentation, Annual National Conference of the Indian Psychiatric Society (ANCIPS), Chandigarh, India, January 29, 2005
(65) Pandurangi, AK: Research and Experience With Risperidone Long-Acting
Injection (CONSTA). Oral Paper Presentation, Annual National Conference of the Indian Psychiatric Society (ANCIPS), Chandigarh, India, January 29, 2005
(66) Pandurangi AK, Lakhani SA: Geropsychiatry Clinical Database: Lessons for the Clinician. Oral Presentation, Annual Conference of the Indian Psychiatric Society, Mumbai, India, January 6, 2006
(67) Pandurangi AK: How Many Psychiatric Hospital Beds are Needed (in Virginia)? Psychiatric Society of Virginia Newsletter, Fall/Winter, 2005, page 4.
(68) VWR Vieweg, Sood AB, Pandurangi, AK, Silverman, JJ: No ‘supersizing’: help
kids on psychotropics avoid weight gain. Current Psychiatry, 2005, 4, 1, 96. (69) Zhang, W., AK Pandurangi, and Peace KE, “Equilibrium-Based Bipolar
Neurological Modeling.” Proc. of 28th Annual Int’l Conf. of IEEE Engineering in Medicine and Biology Society (EMBS), Aug. 30 - Sept. 3, 2006. New York City. Conf Proc IEEE Eng Med Biol Soc. 2006;1:5169-72.
(70) Pandurangi, Ananda K – “Neuromodulation Therapies – Applications in Psychiatry”. Abstract and oral presentation – Annual Conference of the Indian Psychiatric Society, Chennai, India, January 5th, 2007
(71) WR Zhang, AK Pandurangi, KE Peace: Toward a New Computational Standard
for the Classification and Analysis of Bipolar Disorders with Mixed States. Presented at the 2007 Bipolar Conference, University of Pittsburgh, Pittsburgh, PA
(72) Fernandez A, Mathews J, Vieweg WV, Pandurangi, AK: Antidepressants and Suicide in Children and Adolescents in Virginia: Toxicology Findings. New Research Abstracts. Poster presented at the APA Annual Meeting, 2007, San Diego, CA
(73) Pandurangi, Anand K: Invited Book Review. Psychological Medicine. Recovery
From Schizophrenia- An International Perspective. A Report from the WHO Collaborative Project, The International Study of Schizophrenia. Edited by Hopper, K, Harrison G, Janca A, Sartorius N. 2007 Oxford University Press, NY
(74) Pandurangi, AK: Depression Education. Invited presentation at the 1st Indo-US
Health Care Summit, sponsored by AAPI, MCI, IMA and GOI, New Delhi, India, Dec 12-13, 2007
Pandurangi, Ananda K
31
(75) Aggarwal, A. Pandurangi, M. Scherer, A. Kuzel: Am I Different: A
Qualitative Study on barriers to colorectal cancer screening in patients with chronic mental illnesses. Paper presented at Society of General Internal Medicine Meeting, Pittsburg, PA - April 9-12th, 2008
(76) A. Dalkilic, MD, A. Pandurangi: Atypical Antipsychotic Polypharmacy: A
Review of Evidence, Poster presentation at 10th Annual Future Leaders in Psychiatry Meeting, Orlando, FL, sponsor; Emory University, May 22 –25, 2008
(77) Pandurangi, AK: Book Review, Psychological Medicine, 38, 2008, 1515. Physical Illness and Schizophrenia. Authors: S Leucht, T Burkhard, JH Hendersen, M Maj, N Sartorius. Publisher Cambridge University Press, New York, 2008.
(78) Pandurangi, AK: Atypical Polypharmacy. Lecture and abstract, Annual
Conference of the Indian Psychiatric Society, Agra, India, January 8-11, 2009
(79) Pandurangi, AK: Invited Book Review. Psychological Medicine, 2009, 39, 1-2 Hand Book of Schizophrenia, edited by K Muesser & D V Jeste published by Cambridge University Press, New York, 2008
(80) Barker, SB, Pandurangi, A, Knisely J, Burakgazi E, Dalkilic A, McCain N,
Brown, P, Gove C,: Autonomic, Endocrine and Neurophysiologic Correlates of Human-Animal Interaction. Poster/Abstract, 2009 APA Annual Meeting, San Francisco, CA, May 16-21.
(81)(( Pandurangi, AK, Desai, NG & the Mental Health Panel, 2nd Indo-US Health Care
Summit, Mental Health Report, Asian Journal of Psychiatry, 2009, volume 2, page 82. Doi:10.1016/j.ajp.2009.04.011
(82) Vieweg, VWR, Hasnain, M, Pandurangi, AK, Lesnefsky, EJ: Major depression
and coronary artery disease. Letter-to-the-Editor, RE: Kendler et al “Major depression and coronary artery disease in the Swedish Twin Registry. Phenotypic, genetic, and environmental sources of comorbidity” Arch Gen Psychiatry 2009; 66 (8): 857-863; 2010, 67, 6, 653
(83) Pandurangi, Anand K: Book Review. Schizophrenia: Cognitive Theory, Research,
and Therapy. By A. T. Beck, N. A. Rector, N. Stolar and P. Grant. Guilford Publications: New York, NY. 2008. Psychological Medicine, 2009, 39, 2, pp. 2107-2108.
(84) Pandurangi, Anand K, Desai, Nimesh G, and the Delegates of the Mental Health
Panel, 2nd Indo-US Health Care Summit: Mental Health. Monograph. 2nd Indo-US Health Care Summit. , January 2-4, 2009, New Delhi, India. American Association of Physicians From India (AAPI). Chicago, Il, May 2009
(85) Pandurangi, A.K.: The relation of depression with heart disease. Paper presented
at the Psychiatrica 2009 conference, Shanghai, China, August 2, 2009 (86) Rehmani, S.Z., Lakhani, S.A., Pandurangi, A.K.: Pre-senile Dementia in the VCU
Pandurangi, Ananda K
32
Health System Geropsychiatry Clinical Database – Demographics and Causes. Poster presented at the Psychiatric Society of Virginia Fall meeting, Roanoke, Virginia, Sept 26, 2009
(87) Pandurangi, AK: Emerging Neuromodulation Therapies for Treatment Refractory Depression. Abstract/Lecture. Proceedings of the Annual National Conference of the Indian Psychiatry Society (ANCIPS 2010), Jaipur, India
(88) Pandurangi, AK: Acute Psychotic Disorder – A New Classification Based on the
Stress-Vulnerbaility Model. Abstract/Lecture. Proceedings of the Annual National Conference of the Indian Psychiatry Society (ANCIPS 2010), Jaipur, India
(89) Hasnain M, Vieweg V, Baron M, Pandurangi AK: Title: Reply to:
Recommendations on the drug treatment of psychosis in Parkinson's disease. Am. J. Med, 2010, 123, 4, e21
(90) Pandurangi, AK: In Memoriam – Professor S.M. Channabasavanna (1932–2010),
Asian J Psychiat., 2010, 3, 2, 92-93 (91) Cerrato, W, Pandurangi, AK: Adverse Events in a University Hospital Acute
Psychiatry Service. Poster presented at the semi-annual meeting of the Psychiatric Society of Virginia meeting, Sept 11, 2010, Williamsburg, VA
(92) Vieweg, WVR, Hasnain, M, Lesnefsky, EJ, Pandurangi, AK,: Why have we
failed to show that effective treatment of depression in patients with comorbid
coronary heart disease improves cardiac outcome? Letter to the Editor, Psychiatry
and Clinical Neurosciences (JPN) 2011, 65, 2, 203. doi:10.1111/j.1440-
1819.2011.02187.X (93) Pandurangi, AK: Advances in Psychiatric Neuroscience, 2000-2010 – The
Gultamatergic System in Schizophrenia and Depression. ANCIPS, 2011, New Delhi, India
(94) Pandurangi, AK: Evidence Based Treatment Outcomes in Schizophrenia.
Symposium presentation, ANCIPS 2011, New Delhi, India (95) Vieweg VWR, Hasnain M, Wood M, Fernandez A, Lesnefsky EJ, Pandurangi,
AK: Cardiometabolic Risks of Antidepressant and Antipsychotic Drugs, Part I Proarrhythmic Risks of Antidepressant and Antipsychotic Drugs. Psychiatric Times, April 2011, 50-55 (editorial board reviewed CME article)
(96) Vieweg VWR, Hasnain M, Wood M, Fernandez A, Lesnefsky EJ, Pandurangi,
AK: Cardiometabolic Risks of Antidepressant and Antipsychotic Drugs, Part II Metabolic and Cardiac Risks of Antidepressant and Antipsychotic Drugs. Psychiatric Times, May 2011, (editorial board reviewed CME article)
Pandurangi, Ananda K
33
(97) Pandurangi, AK: International Link Projects in Psychiatric Education and Practice: Challenges and Opportunities. Symposium presentation at the 2011 annual meeting of the American Psychiatric Association, Honolulu, Hawaii, May 17, 2011.
(98) Pandurangi, AK: Book Review. The Psychosis Risk Syndrome – Handbook of Diagnosis and Follow-Up. Authors: McGlashan, TH, Walsh, BC, and Woods,SW,
Oxford University Press: 2010 New York, NY. Psychological Medicine, 41, 08, pp. 1785-1786.
(99) Pandurangi, AK: Brain Stimulation Therapies in Psychiatry. Abstract/Lecture. Proceedings of the Annual National Conference of the Indian Psychiatry Society (ANCIPS 2012), January 20, 2012, Kochi, India (100) Pandurangi, AK: Schizophrenia Co-Morbidity. Abstract/Symposium Presentation, Annual National Conference of the Indian Psychiatry Society (ANCIPS), Kochi, January 20, 2102
